Journal article
Actuation of CRP activating region 3 by formylation modulates the Vibrio cholerae response to oxidative DNA damage
Proceedings of the National Academy of Sciences - PNAS, Vol.123(37), e2602861123
09/15/2026
DOI: 10.1073/pnas.2602861123
PMID: 42721080
Abstract
The cyclic AMP receptor protein or CRP is a global regulator of bacterial metabolism. CRP activates transcription of genes required for utilization of alternative carbon sources in response to the second messenger cAMP, which is synthesized in the setting of glucose scarcity. Transcription is activated through contact with RNA polymerase at three sites termed activating regions (ARs) 1-3. AR3 was previously reported to be functional only when CRP K52 was mutated to a neutral residue and to be essential for transcription only in the absence of AR1 and AR2. To probe the role of AR3 at the genome level, we used chromatin immunoprecipitation sequencing and RNA sequencing to compare WT CRP with a CRP K52Q mutant. This mutation resulted in hundreds of novel CRP chromosomal binding sites and differentially regulated transcripts including the small RNA CrbZ which represses acetate utilization. CrbZ was expressed by wild-type
only in cultures grown to stationary phase in maltose, and proteomic analysis of CRP isolated under these conditions demonstrated formylation of CRP K52. N
-lysine formylation arises from a reaction with a high energy formylphosphate, which is a byproduct of oxidative DNA damage. Consistent with this, we find that CRP K52Q activates transcription of genes involved in the response to oxidative stress, DNA repair, and protein refolding as well as virulence and catabolism of specific carbon sources. We propose a model in which CRP K52 formylation signals oxidative DNA damage and alters the CRP regulon to protect the cell.
Details
- Title: Subtitle
- Actuation of CRP activating region 3 by formylation modulates the Vibrio cholerae response to oxidative DNA damage
- Creators
- Renato E R S Santos - Harvard Medical SchoolPallabi Basu - Boston Children's HospitalBrendan J O'Hara - Harvard Medical SchoolJacob A Gibson - Boston Children's HospitalMichael J Gebhardt - University of IowaChris Akut - Boston Children's HospitalWilliam P Robins - Harvard UniversityJohn J Mekalanos - Harvard UniversitySimon L Dove - Boston Children's HospitalPaula I Watnick - Boston Children's Hospital
- Resource Type
- Journal article
- Publication Details
- Proceedings of the National Academy of Sciences - PNAS, Vol.123(37), e2602861123
- DOI
- 10.1073/pnas.2602861123
- PMID
- 42721080
- NLM abbreviation
- Proc Natl Acad Sci U S A
- ISSN
- 1091-6490
- eISSN
- 1091-6490
- Publisher
- National Academy of Sciences
- Grant note
- R01 AI112652 / NIAID NIH HHS R01 AI112652 / HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI162701 / NIAID NIH HHS R01AI018045 / HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F32AI86459 / HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI158247 / NIAID NIH HHS
- Language
- English
- Date published
- 09/15/2026
- Academic Unit
- Microbiology and Immunology
- Record Identifier
- 9985224437402771
Metrics
2 Record Views